HPV
Becton Dickinson's HPV assay was FDA-approved for use with clinician-collected samples in 2018 and received approval for sample self-collection in May.
Becton Dickinson Gets Health Canada Approval for HPV Test With Self-Collected Samples
The firm said that the updated approval will improve access to HPV testing by providing a less invasive and less expensive alternative to Pap tests.
Predica Diagnostics Developing Targeted Sequencing Test for Cervical Cancer Diagnosis, Screening
Premium
The test is based on targeted circular probe-based RNA next-generation sequencing (ciRNAseq), which enables a high degree of multiplexing and mutational analysis.
Roche Molecular HPV Test Receives WHO Prequalification
The prequalification designations are for the test's use on the Cobas 5800 platform and for use with self-collected samples on the Cobas 5800, 6800, and 8800 instruments.
Researchers Highlight Progress in Head and Neck Cancer MRD at ASCO, but Results Remain Preliminary
Premium
Clinicians said that residual disease tests could be of great benefit to this population, but advancing technologies will still have to prove themselves.